Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| Therapy Name | STA551 |
| Synonyms | |
| Therapy Description |
STA551 is an ATP-dependent agonist antibody that targets CD137, potentially resulting in the activation of T cells and decreased tumor growth (PMID: 32847940). |
| Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
|---|---|---|---|---|
| STA551 | STA 551|STA-551 | TNFRSF9 Antibody 36 | STA551 is an ATP-dependent agonist antibody that targets CD137, potentially resulting in the activation of T cells and decreased tumor growth (PMID: 32847940). |
| Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
|---|
| Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
|---|